CellOrigin Biotech (Hangzhou) Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CellOrigin Biotech (Hangzhou) Co., Ltd. - overview
Established
2018
Location
Hangzhou, -, China
Primary Industry
Biotechnology
About
Based in Hangzhou, China and established in 2018, CellOrigin Biotech (Hangzhou) Co. , Ltd. is a biotech company that focuses on the research and development of genetically engineered pluripotent stem cells to genetically engineered pluripotent stem cells (iPSC) derived immune cell therapies. Jin Zhang, the founder of the company, used to be a scientist at Amgen before he established the company.
The company has set up R&D center and production base in Hangzhou. The team members graduated from Harvard University, Zhejiang University, Scripps Research Institute and domestic pharmaceutical companies. CellOrigin Biotech (Hangzhou) Co. , Ltd.
has obtained core patents internationally and domestically. In September 2023, it raised series C funding. The company engages in the research and development of iPSC-derived innate immune cell therapies. It has established a clinical-grade iPSC cell bank.
The company has established three major technology platforms: a clinical-level iPSC cell bank, a clone-engineered iPSC technology platform, and an iPSC targeted and efficient differentiation immune cell technology platform. It also has drug development pipelines such as CAR-Mac MB01 and CAR-Mac MB02.
Current Investors
Shulan Junjie Capital, Nest.Bio Labs, Shanhai Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.cellorigin.net
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.